Good Life Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Good Life Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$324K	Sell	5,165 -263	-5%	-$15.8K	0.02%	384
2025 Q1	$327K	Sell	5,428 -225	-4%	-$14K	0.02%	366
2024 Q4	$330K	Sell	5,653 -8,791	-61%	-$522K	0.02%	359
2024 Q3	$855K	Buy	14,444 +6,623	+85%	+$378K	0.05%	240
2024 Q2	$438K	Sell	7,821 -38	-0.5%	-$2.13K	0.04%	287
2024 Q1	$460K	Sell	7,859 -45	-0.6%	-$2.54K	0.04%	264
2023 Q4	$427K	Sell	7,904 -782	-9%	-$38.2K	0.04%	258
2023 Q3	$421K	Sell	8,686 -3,132	-27%	-$167K	0.05%	235
2023 Q2	$667K	Sell	11,818 -678	-5%	-$37.3K	0.08%	187
2023 Q1	$675K	Sell	12,496 -433	-3%	-$23.1K	0.09%	171
2022 Q4	$680K	Buy	12,929 +108	+0.8%	+$5.48K	0.09%	171
2022 Q3	$605K	Sell	12,821 -94	-0.7%	-$4.88K	0.09%	165
2022 Q2	$651K	Sell	12,915 -1,161	-8%	-$63.3K	0.09%	163
2022 Q1	$858K	Sell	14,076 -60	-0.4%	-$3.58K	0.11%	141
2021 Q4	$931K	Sell	14,136 -1,090	-7%	-$69.8K	0.11%	139
2021 Q3	$956K	Buy	15,226 +2,794	+22%	+$178K	0.13%	132
2021 Q2	$748K	Sell	12,432 -138	-1%	-$7.98K	0.14%	117
2021 Q1	$692K	Sell	12,570 -126	-1%	-$6.99K	0.14%	126
2020 Q4	$691K	Sell	12,696 -42	-0.3%	-$2.19K	0.16%	109
2020 Q3	$632K	Sell	12,738 -666	-5%	-$32.3K	0.17%	105
2020 Q2	$588K	Buy	13,404 +768	+6%	+$32.8K	0.18%	100
2020 Q1	$473K	Buy	12,636 +12	+0.1%	+$505	0.17%	105
2019 Q4	$553K	Buy	12,624 +486	+4%	+$20.4K	0.16%	114
2019 Q3	$498K	Buy	12,138 +3,336	+38%	+$137K	0.15%	119
2019 Q2	$354K	Buy	8,802 +1,770	+25%	+$67K	0.1%	145
2019 Q1	$271K	Buy	7,032 +822	+13%	+$29.8K	0.08%	181
2018 Q4	$207K	Hold	6,210	–	–	0.07%	211
2018 Q3	$235K	Sell	6,210 -534	-8%	-$19K	0.07%	211
2018 Q2	$226K	Sell	6,744 -450	-6%	-$14.7K	0.07%	200
2018 Q1	$217K	Sell	7,194 -192	-3%	-$5.91K	0.07%	193
2017 Q4	$223K	Hold	7,386	–	–	0.07%	203
2017 Q3	$206K	Sell	7,386 -540	-7%	-$14.9K	0.08%	195
2017 Q2	$217K	Buy	+7,926	New	+$210K	0.1%	185

Other funds holding IHI

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Good Life Advisors's IHI Position: Q2 2025 in Review

Good Life Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 4.8% in Q2 2025, selling an estimated $15.8K and leaving 5,165 shares worth $324K. The position accounts for 0.02% of the portfolio, ranked #384.

Good Life Advisors first reported a position in IHI in Q2 2017 and has held it in 33 quarters since. The position peaked at $956K in Q3 2021. 547 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

Good Life Advisors held 5,165 shares of iShares US Medical Devices ETF worth $324K as of Q2 2025.
Good Life Advisors sold 263 iShares US Medical Devices ETF shares in Q2 2025, an estimated $15.8K.
iShares US Medical Devices ETF made up 0.02% of Good Life Advisors's portfolio in Q2 2025, its #384 holding.
Good Life Advisors first reported a position in iShares US Medical Devices ETF in Q2 2017 and has held it in 33 quarters since.
Good Life Advisors's iShares US Medical Devices ETF position peaked at $956K in Q3 2021.
547 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.